Drug recall · March 10, 2021
Progesterone Capsules recall
Why: Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.
- Lots / codes
Batch # 1399851P1, Exp 02/2021
- Quantity
- 16,449 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- February 26, 2021 · Voluntary: Firm initiated
- Classified
- March 3, 2021
- Reported
- March 10, 2021
- Ended
- February 17, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Progesterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.